Ok how about this as a starting point?
Possibly 1 out of 5 - the one being MSB - I'll check them all when you have 5.
Amplia Therapeutics Annual Report YE 31/3/23 pg48 “going concern” and audit report pg65
Last year. This is 2024.
Pharmaxis AR YE 30/6/23 pg33 “going concern” and audit report pg62
Same.
Mesoblast AR YE 30/6/24 pg6 “Risks; accumulated deficit $908.8 million; require substantial additional financing” and pg169 “going concern - material uncertainty”
Possibly 1 out of 5.
Neuren Pharmaceuticals AR YE 31/12/20 pg36 “material uncertainties and going concern basis”
Four years ago.
Actinogen Medical AR YE 30/6/23 pg43 “going concern” and audit report pg64
Last year.
I think you now owe me an apology and you need to consider retracting your comments in relation to my post!
Not yet.
Screenshot(s) from Annual Report of 29 Aug 24, page-12
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $29.06K | 131.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 951 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |